Armenia vs Oman: Previously treated cases tested for RR-/MDR-TB
Armenia
100.0%
in 2024
Oman
100.0%
in 2024
Armenia rank
1st
Oman rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Armenia
- Oman
How they compare
Armenia currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
Across all 19 years both countries report, Oman has been ahead every year.
Armenia ranks 1st and Oman ranks 1st of 180 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Armenia | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.4% | 100.0% | 55.6% | Oman |
| 2010s | 39.7% | 96.9% | 57.2% | Oman |
| 2020s | 98.0% | 100.0% | 2.0% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Armenia or Oman?
- Armenia, at 100.0% against 100.0% in Oman as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Armenia and Oman?
- 0.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Oman?
- 19 years are reported by both, from 2005 to 2024.
- How do Armenia and Oman rank globally for previously treated cases tested for rr-/mdr-tb?
- Armenia ranks 1st and Oman ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.